BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2109101)

  • 1. Assembly of gag-beta-galactosidase proteins into retrovirus particles.
    Jones TA; Blaug G; Hansen M; Barklis E
    J Virol; 1990 May; 64(5):2265-79. PubMed ID: 2109101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport and assembly of gag proteins into Moloney murine leukemia virus.
    Hansen M; Jelinek L; Whiting S; Barklis E
    J Virol; 1990 Nov; 64(11):5306-16. PubMed ID: 1698996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.
    Choi G; Park S; Choi B; Hong S; Lee J; Hunter E; Rhee SS
    J Virol; 1999 Jul; 73(7):5431-7. PubMed ID: 10364290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
    Ory DS; Neugeboren BA; Mulligan RC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of HIV GAG-B-galactosidase fusion proteins into virus particles.
    Wang CT; Stegeman-Olsen J; Zhang Y; Barklis E
    Virology; 1994 May; 200(2):524-34. PubMed ID: 8178440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
    J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence requirements for incorporation of human immunodeficiency virus gag-beta-galactosidase fusion proteins into virus-like particles.
    Wang CT; Lai HY; Yang CC
    J Med Virol; 1999 Oct; 59(2):180-8. PubMed ID: 10459153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
    VanBrocklin M; Federspiel MJ
    Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells.
    Guibinga GH; Miyanohara A; Esko JD; Friedmann T
    Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.
    Crawford S; Goff SP
    J Virol; 1985 Mar; 53(3):899-907. PubMed ID: 3882995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of membrane-bound retrovirus capsid proteins.
    Barklis E; McDermott J; Wilkens S; Schabtach E; Schmid MF; Fuller S; Karanjia S; Love Z; Jones R; Rui Y; Zhao X; Thompson D
    EMBO J; 1997 Mar; 16(6):1199-213. PubMed ID: 9135137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane.
    Rhee SS; Hui HX; Hunter E
    J Virol; 1990 Aug; 64(8):3844-52. PubMed ID: 2370682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic assay for multimerization of retroviral gag polyproteins.
    Luban J; Alin KB; Bossolt KL; Humaran T; Goff SP
    J Virol; 1992 Aug; 66(8):5157-60. PubMed ID: 1629970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
    Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
    J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and composition of intracellular particles formed by Moloney murine leukemia virus.
    Hansen M; Jelinek L; Jones RS; Stegeman-Olsen J; Barklis E
    J Virol; 1993 Sep; 67(9):5163-74. PubMed ID: 8350394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures.
    Schumann G; Qin L; Rein A; Natsoulis G; Boeke JD
    J Virol; 1996 Jul; 70(7):4329-37. PubMed ID: 8676455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
    Abe A; Chen ST; Miyanohara A; Friedmann T
    J Virol; 1998 Aug; 72(8):6356-61. PubMed ID: 9658075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins.
    Morgan RA; Nussbaum O; Muenchau DD; Shu L; Couture L; Anderson WF
    J Virol; 1993 Aug; 67(8):4712-21. PubMed ID: 8331726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
    Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
    J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.